Immunohistochemical status of PD-L1 in thymoma and thymic carcinoma.

ホーム > 研究業績 > 原著論文 > Immunohistochemical status of PD-L1 in thymoma and thymic carcinoma.

Lung Cancer. 2015 May;88(2):154-9.

Katsuya Y, Fujita Y, Horinouchi H, Ohe Y, Watanabe S, Tsuta K.

Chemotherapy-Regulated microRNA-125-HER2 Pathway as a Novel Therapeutic Target for Trastuzumab-Mediated Cellular Cytotoxicity in Small Cell Lung Cancer.

Development of small RNA delivery systems for lung cancer therapy.

前のページに戻る